Furthermore, this non-canonical immunomodulatory activity of C4BP(β-) is independent of anticoagulant PS and, therefore, would additionally benefit systemic inflammatory and hypercoagulable conditions such as sepsis (59). This evidence concerns the gene C4BPB and Sepsis.